Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Mifamurtide> ?p ?o. }
Showing items 1 to 63 of
63
with 100 items per page.
- Mifamurtide abstract "Mifamurtide (trade name Mepact, marketed by Takeda) is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults, which is lethal in about a third of cases. The drug was approved in Europe in March 2009.".
- Mifamurtide atcPrefix "L03".
- Mifamurtide atcSuffix "AX15".
- Mifamurtide casNumber "83461-56-7".
- Mifamurtide casSupplemental "(mifamurtide sodium · xH2O)".
- Mifamurtide fdaUniiCode "EQD2NNX741".
- Mifamurtide iupacName "2-[(N-{(2R)-[(2-acetamido-2,3-dideoxy-D-glucopyranos-3-yl)oxy]-propanoyl}-(L)-alanyl-(D)-isoglutaminyl-(L)-alanyl)amino]ethyl (2R)-2,3-bis(hexadecanoyloxy)propyl hydrogen phosphate".
- Mifamurtide pubchem "23725093".
- Mifamurtide thumbnail Mifamurtide.svg?width=300.
- Mifamurtide wikiPageID "25044219".
- Mifamurtide wikiPageRevisionID "602301543".
- Mifamurtide atcPrefix "L03".
- Mifamurtide atcSuffix "AX15".
- Mifamurtide bioavailability "N/A".
- Mifamurtide c "59".
- Mifamurtide casNumber "83461".
- Mifamurtide eliminationHalfLife "64800.0".
- Mifamurtide eliminationHalfLife "minutes".
- Mifamurtide h "109".
- Mifamurtide hasPhotoCollection Mifamurtide.
- Mifamurtide iupacName "2".
- Mifamurtide kegg "D06619".
- Mifamurtide legalStatus "Rx".
- Mifamurtide licenceEu "Mepact".
- Mifamurtide molecularWeight "1237.499".
- Mifamurtide n "6".
- Mifamurtide o "19".
- Mifamurtide p "1".
- Mifamurtide pregnancyCategory "not investigated".
- Mifamurtide pubchem "23725093".
- Mifamurtide routesOfAdministration "intravenous liposomal infusion over one hour".
- Mifamurtide smiles "CCCCCCCCCCCCCCCCOCCOCCCCCCCCCCCCCCCC".
- Mifamurtide unii "EQD2NNX741".
- Mifamurtide verifiedfields "changed".
- Mifamurtide verifiedrevid "407798436".
- Mifamurtide width "300".
- Mifamurtide subject Category:Immunostimulants.
- Mifamurtide subject Category:Orphan_drugs.
- Mifamurtide type Agent114778436.
- Mifamurtide type CausalAgent100007347.
- Mifamurtide type Drug103247620.
- Mifamurtide type Matter100020827.
- Mifamurtide type OrphanDrugs.
- Mifamurtide type PhysicalEntity100001930.
- Mifamurtide type Substance100020090.
- Mifamurtide type Drug.
- Mifamurtide type DrugProduct.
- Mifamurtide type FunctionalSubstance.
- Mifamurtide comment "Mifamurtide (trade name Mepact, marketed by Takeda) is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults, which is lethal in about a third of cases. The drug was approved in Europe in March 2009.".
- Mifamurtide label "Mifamurtid".
- Mifamurtide label "Mifamurtide".
- Mifamurtide label "Mifamurtide".
- Mifamurtide label "Mifamurtyd".
- Mifamurtide sameAs Mifamurtid.
- Mifamurtide sameAs Mifamurtyd.
- Mifamurtide sameAs Mifamurtide.
- Mifamurtide sameAs m.09gnktt.
- Mifamurtide sameAs Q411175.
- Mifamurtide sameAs Q411175.
- Mifamurtide sameAs Mifamurtide.
- Mifamurtide wasDerivedFrom Mifamurtide?oldid=602301543.
- Mifamurtide depiction Mifamurtide.svg.
- Mifamurtide isPrimaryTopicOf Mifamurtide.